Chief Medical Director Kari Syrjänen will retire from Biohit Oyj
Biohit Oyj 31.12.2018 12:00 Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31[st] of December 2018. Kari Syrjänen has been employed by Biohit since 2013. ”I would like to thank Kari for the excellent work during these years”, says Semi Korpela, President and CEO of Biohit.Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit Oyj in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for